Differences in access and patient outcomes across antiretroviral treatment clinics in the Free State province: a prospective cohort study

Ingle, Suzanne M; May, Margaret; Uebel, Kerry; Timmerman, Venessa; Kotze, Eduan; Bachmann, Max; Sterne, Jonathan A C; Egger, Matthias; Fairall, Lara (2010). Differences in access and patient outcomes across antiretroviral treatment clinics in the Free State province: a prospective cohort study. SAMJ. South African medical journal, 100(10), pp. 675-681. Cape Town: Medical Association of South Africa

Preview

Text Ingle SAfrMedJ 2010.pdf - Published Version Available under License Publisher holds Copyright. Download (171kB) | Preview

Objective. To assess differences in access to antiretroviral treatment
(ART) and patient outcomes across public sector treatment facilities in the Free State province, South Africa.
Design. Prospective cohort study with retrospective database linkage. We analysed data on patients enrolled in the treatment programme across 36 facilities between May 2004 and December 2007, and assessed percentage initiating ART and percentage dead at 1 year after enrolment. Multivariable logistic regression was used to estimate associations of facility-level and patient-level characteristics with both mortality and treatment status.
Results. Of 44 866 patients enrolled, 15 219 initiated treatment within 1 year; 8 778 died within 1 year, 7 286 before accessing ART. Outcomes at 1 year varied greatly across facilities and more variability was explained by facility-level factors than by
patient-level factors. The odds of starting treatment within 1 year improved over calendar time. Patients enrolled in facilities with treatment initiation available on site had higher odds of starting treatment and lower odds of death at 1 year compared with those enrolled in facilities that did not offer treatment initiation. Patients
were less likely to start treatment if they were male, severely immunosuppressed (CD4 count ≤50 cells/μl), or underweight (<50 kg). Men were also more likely to die in the first year after enrolment.
Conclusions. Although increasing numbers of patients started ART between 2004 and 2007, many patients died before accessing ART. Patient outcomes could be improved by decentralisation of treatment services, fast-tracking the most immunodeficient
patients and improving access, especially for men.

Interest & Impact

Downloads

191 since deposited on 04 Oct 2013
8 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item